• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 27VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 11/07/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
(b)(4).It was reported that on (b)(6) 2022, a 27mm sjm masters series valsalva aortic valved graft was implanted into a patient.On (b)(6) 2022, the patient was noted to have pericardial effusion resulting in pericardial tamponade.On (b)(6) 2022, surgical intervention was performed to decompress the tamponade.No additional information was provided.
 
Manufacturer Narrative
An event of pericardial effusion resulting in pericardial tamponade was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that the pericardial effusion was believed to be related to the procedure.There was no allegation of malfunction against the abbott device.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Event Description
(b)(4) - valved grafts pas, patient site id: (b)(6).Subsequent to the previously filed report, additional information was received that on (b)(6) 2022, the patient was also transfused plasma.The patient is reported to be stable and discharge.The event occurred prior to discharge from the hospital.It is thought that the event is related to the procedure, but not to the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15910410
MDR Text Key304785863
Report Number2135147-2022-02325
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009515
UDI-Public05414734009515
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2023
Device Model Number27VAVGJ-515
Device Catalogue Number27VAVGJ-515
Device Lot Number8446965
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/25/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient SexMale
Patient Weight99 KG
Patient RaceWhite
-
-